Listas | Seção | Observação |
---|---|---|
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Outras observações: The medicines should only be used within an established support programme. Therapeutic alternatives: buprenorphine |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Outras observações: The medicines should only be used within an established support programme. Therapeutic alternatives: buprenorphine |
Listas | Seção | Observação |
---|---|---|
Chile | Essential and Prioritized Medications | Sem observações |
Listas | Seção | Observação |
---|---|---|
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Outras observações: The medicines should only be used within an established support programme. Therapeutic alternatives: buprenorphine |
Listas | Seção | Observação |
---|---|---|
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain. |
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Outras observações: The medicines should only be used within an established support programme. Therapeutic alternatives: buprenorphine |
Listas | Seção | Observação |
---|---|---|
Bolivia | LINAME 2011 - 2013 | Sem observações |
Colombia | 8.0 Toxicology | Sem observações |
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain |
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |
Listas | Seção | Observação |
---|---|---|
Chile | Essential and Prioritized Medications | Sem observações |
Training CSamouge 2022 | 2.2 Opioid analgesics |
Outras observações: For the management of cancer pain. |
WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Outras observações: For the management of cancer pain. |